key: cord-1041076-eqcqrz6w authors: Nur, Erfan; Gaartman, Aafke E.; van Tuijn, Charlotte F. J.; Tang, Man Wai; Biemond, Bart J. title: Vaso‐occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID‐19) date: 2020-04-21 journal: Am J Hematol DOI: 10.1002/ajh.25821 sha: f839fe136f825e10e702506d5d719a48eacbd239 doc_id: 1041076 cord_uid: eqcqrz6w nan In March 2020, during the 2019 novel coronavirus disease pandemic, caused by the newly emerged virus SARS-CoV-2, two patients with homozygous sickle cell disease (SCD) were admitted to our hospital with a painful vaso-occlusive crisis (VOC) triggered by COVID-19. Both patients had no flu-like complaints characteristic of COVID-19 during or preceding the VOC episode. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group Acute chest syndrome in sickle cell disease due to the new influenza A (H1N1) virus infection Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19)